rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Biote Corp.

BTMD · Nasdaq

Health CarePharmaceuticalsNot moving yet

BTMD stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 40.2% below that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
32% -7 in 4 wk
Insider buys, 12 months
$404K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
72 (-9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
26%34%43%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$6.7MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
Marc D. BeerExecutive Chairmanbought16,000at $1.5511 Aug 2026filed 12 Aug 2026
Marc D. BeerExecutive Chairmanbought115,950at $1.5310 Aug 2026filed 12 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders72-9 on the quarter
New · exited18 · 27
Reported value$23.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
325 CAPITAL LLCunchanged · filed 14 Aug 20264,548,127$8.6M00.0%
Bandera Partners LLCunchanged · filed 12 Aug 20262,065,482$3.9M00.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20261,102,753$2.1M-11,102−1.0%
MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 2026436,088$824K+436,088
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026431,962$816K-111,532−20.5%
BlackRock, Inc.reduced · filed 7 Aug 2026365,945$692K-1,373,299−79.0%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026301,310$569K+301,310
RICE HALL JAMES & ASSOCIATES, LLCadded · filed 7 Aug 2026262,842$497K+12,823+5.1%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026260,488$493K-355,174−57.7%
JANE STREET GROUP, LLCnew · filed 14 Aug 2026253,313$479K+253,313
31 Mar 2023 – 30 Jun 2026
265787Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Marc D. Beer Company insiderExecutive Chairman · last 11 Aug 20263 · 1
Robert Charles Peterson Company insiderInterim CEO · last 12 Jun 20260 · 2
Bret Christensen Company insiderDirector · last 8 Jun 20261 · 0
Andrew R. Heyer Company insiderDirector · last 12 May 20262 · 0
Dana Lynn Jacoby Company insiderDirector · last 12 May 20260 · 0
Debra L. Morris Company insiderDirector · last 12 May 20261 · 0
Richard R. Barrera Company insiderDirector, 10% owner · last 12 May 20263 · 0
Stephen Mark Cone Company insiderDirector · last 12 May 20262 · 0
Daniel Michael Monico Company insiderGeneral Counsel · last 1 May 20260 · 0
Steven J. Heyer Company insiderDirector · last 13 May 20250 · 0
Rb Management Gp Llc Company insider10% owner · last 30 Apr 20257 · 0
Guines Llc Company insider10% owner · last 17 Apr 20258 · 0

Same industry

ABBV AbbVieLeading+19%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202518.5%
Free cash flow marginFY 2025 · to 31 Dec 202515.7%
Return on capital employedFY 2025 · to 31 Dec 202556.8%
Cash conversionFY 2025 · to 31 Dec 2025130%
Cash and equivalentsFY 2025 · to 31 Dec 2025$24.1M
Free cash flowFY 2025 · to 31 Dec 2025$30.2M

Analyst forecasts

No analyst forecasts yet.